Victory Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $142K | Sell |
|
|||||
|
2023
Q3 | $455K | Buy |
|
|||||
|
2023
Q2 | $561K | Buy |
|
|||||
|
2023
Q1 | $527K | Sell |
|
|||||
|
2022
Q4 | $836K | Buy |
|
|||||
|
2022
Q3 | $662K | Buy |
|
|||||
|
2022
Q2 | $939K | Sell |
|
|||||
|
2022
Q1 | $955K | Sell |
|
|||||
|
2021
Q4 | $1.26M | Buy |
|
|||||
|
2021
Q3 | $1.05M | Buy |
|
|||||
|
2021
Q2 | $406K | Buy |
|
|||||
|
2021
Q1 | $259K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $266K | Sell |
|
|||||
|
2020
Q2 | $319K | Sell |
|
|||||
|
2020
Q1 | $710K | Buy |
|
|||||
|
2019
Q4 | $696K | Buy |
|
|||||
|
2019
Q3 | $382K | Buy |
|
|||||
|
2019
Q2 | $96K | Sell |
|
|||||
|
2019
Q1 | $239K | Sell |
|
|||||
|
2018
Q4 | $195K | Sell |
|
|||||
|
2018
Q3 | $35.5M | Sell |
|
|||||
|
2018
Q2 | $50.4M | Sell |
|
|||||
|
2018
Q1 | $53.7M | Sell |
|
|||||
|
2017
Q4 | $56.1M | Buy |
|
|||||
|
2017
Q3 | $58.3M | Buy |
|
|||||
|
2017
Q2 | $76.4M | Sell |
|
|||||
|
2017
Q1 | $89M | Buy |
|
|||||
|
2016
Q4 | $68.5M | Buy |
|
|||||
|
2016
Q3 | $48.3M | Buy |
|